TRI BOARD of directors

Read about the members of the TRI Board of Directors below. 




Professor David Siddle, BA (Hons), PhD, FASSA


David Siddle obtained his PhD from the University of Queensland in 1971. As an academic psychologist, he worked in universities in England, Canada and Australia. After appointments at Macquarie University, University of Tasmania, and the University of Queensland, he was appointed as Pro-Vice-Chancellor (Research) at the University of Sydney in 1997. He served as Deputy Vice-Chancellor (Research) at the University of Queensland from 2001 to 2009 where he was responsible for the development and implementation of policy designed to enhance the university’s performance in research and research training.  He was Chair of the Humanities and Social Sciences Panel of the Australian Research Council in 1993 and 1994 and after retirement, served on the Australian Research Council’s Advisory Council. He has served as a Board member for many Cooperative Research Centres, was a Director of the Australian Synchrotron Company and from 2011 to 2014, served as a member of the Higher Education Standards Panel. Until 2017, he was Chair of Brisbane Diamantina Health Partners.




Prof Robyn Ward is the Deputy Vice Chancellor (Research) at The University of Queensland.  She took up this role after many years of work within hospital and academic settings in New South Wales, including Director of the Prince of Wales Cancer Centre and Clinical Associate Dean at the University of New South Wales (UNSW).

Until the end of 2015, Professor Ward was the Director of the Translational Cancer Research Network, a multi-institutional group based in NSW and supported by the Cancer Institute NSW; while for the Commonwealth, she chairs the Medical Services Advisory Committee and is a long standing member of the Pharmaceutical Benefits Advisory Committee.  Professor Ward was chair of the NHMRC’s Human Genetics Advisory Council and Member of the NHMRC council until June 2015.

Throughout her career, Professor Ward has shown a sustained capacity for innovative research into the range of issues that underlie the problem of human cancer. At UNSW, Professor Ward led an independent research group that has produced over 200 journal articles, letters and monographs, as well as several patents. As Head of the Adult Cancer Program at the Lowy Cancer Research Centre UNSW, and prior to that as a clinician researcher at St Vincent’s Hospital Sydney, she has made several important contributions to translational cancer research in the area of bowel cancer, including studies of the precursor lesions of this common disease, and the development of novel immunotherapies. More recently, she has used her expertise as a medical oncologist and clinical cancer geneticist to better define population-based screening strategies for hereditary bowel cancer. By recognising that constitutional epimutations of tumour suppressor genes can predispose to cancer, she has also helped to better define the medical management of individuals and families with these epigenetic changes.


PROFESSOR Carol Dickenson AM BBus (Mgt) QIT, PhD UQ

Senior Deputy Vice-Chancellor (QUT)

Professor Carol Dickenson AM is Senior Deputy Vice-Chancellor at the Queensland University of Technology (QUT). QUT’s six faculties and its research institutes report to the Senior Deputy Vice-Chancellor. The role includes responsibility for strategic planning, academic staffing and enterprise bargaining. Professor Dickenson is Chair of University Academic Board.

Prior to her appointment as Senior Deputy Vice-Chancellor, Professor Dickenson served as QUT’s Registrar for 10 years and possesses a unique set of skills honed during extensive experience across academic, consulting, government, HR, and executive management roles.

Carol’s external roles include: Elected Member, AHEIA Executive Committee; Member, Universities Australia D/PVC (A) Group; Member, ATN DVC (A) Group; Member, Chairs of Academic Boards; Chartered Member – Australian Human Resources Institute (AHRI); Member – AHRI National Certification Council; Director, Translational Research Institute.




Dr Ashby is one of the state’s most experienced clinicians and health administrators. In 2010, Dr Ashby was awarded a Member of the General Division of the Order of Australia for service to emergency medicine, to medical administration, and to a range of professional associations. He is active across a broad range of medical areas, including teaching, research and consultancy.

Dr Ashby was most recently the Executive Director and Director of Medical Services at the Princess Alexandra Hospital (PAH). He was appointed Director of Emergency Medicine at the Royal Brisbane Hospital in 1989, a post he held until his appointment as Executive Director Medical Services at the Royal Brisbane and Women’s Hospital (RBWH) in 2000. In the period 2000-2006, he also acted as District Manager at both the RBWH and PAH for lengthy periods.

Dr Ashby contributes to a significant number of organisations/committees. His roles include: Member, Australian Medical Council; Vice President Royal Australasian College of Medical Administrators (2010-2012); Board Member, Diamantina Health Partners; Board Member, Australian e-Health Research Centre; Member, e-Health Governance Board (Queensland Health) Chair, Queensland Policy and Advisory Committee on Health Technology; Member Queensland Health Renewal Executive Committee; Member, Queensland Health Clinical Innovation Board

Dr Ashby’s qualifications: MB BS University of Queensland 1976; Bachelor of Health Administration, University of New South Wales, 1986; Fellow, Royal Australian College of General Practitioners 1983 (FRACGP); Fellow, Australasian College for Emergency Medicine 1984 (FACEM); Fellow, Royal Australasian College of Medical Administrators 1986 (FRACMA).




Jim Walker is the Vice President and Managing Director of Rockwell Collins Asia Pacific.  Employing over 20,000 people, Rockwell Collins is one of the largest suppliers of avionics and communications' products to  the global aerospace and defence industries.

Jim has over 30 years’ experience in engineering, manufacturing and technology development in the aerospace industry. He has been the CEO of a number of companies and was also General Manager of The Boeing Company's Network Enabled Systems Business Unit in Australia. Prior to this, Jim served in the Royal Australian Air Force working in the areas of satellite operations, communications, intelligence, engineering and training.

Jim has held a number of Board appointments throughout his career and is currently the Chair of Mater Research and is a Director on the China Eastern and Rockwell Collins Joint venture in Shanghai.  Jim is a Member of the Order of Australia, an award which recognises his contribution to the Australian aerospace industry.